Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20194851

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Apr 1
First author
Rutkowski P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rutkowski P
      type
      Author
    2. name
      Van Glabbeke M
      type
      Author
    3. name
      Rankin CJ
      type
      Author
    4. name
      Ruka W
      type
      Author
    5. name
      Rubin BP
      type
      Author
    6. name
      Debiec-Rychter M
      type
      Author
    7. name
      Lazar A
      type
      Author
    8. name
      Gelderblom H
      type
      Author
    9. name
      Sciot R
      type
      Author
    10. name
      Lopez-Terrada D
      type
      Author
    11. name
      Hohenberger P
      type
      Author
    12. name
      van Oosterom AT
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Rutkowski P
      type
      Author
    2. name
      Van Glabbeke M
      type
      Author
    3. name
      Rankin CJ
      type
      Author
    4. name
      Ruka W
      type
      Author
    5. name
      Rubin BP
      type
      Author
    6. name
      Debiec-Rychter M
      type
      Author
    7. name
      Lazar A
      type
      Author
    8. name
      Gelderblom H
      type
      Author
    9. name
      Sciot R
      type
      Author
    10. name
      Lopez-Terrada D
      type
      Author
    11. name
      Hohenberger P
      type
      Author
    12. name
      van Oosterom AT
      type
      Author
    bibliography ids
    1. nci-bib-a4096b036e17d9b3536964a8
    book metadata
    content sha256
    a3de9c3b504cc686e78d256bd5b010c250a648c9fabdaf646c84abb7bc8bac4a
    document type
    citation
    dois
    1. 10.1200/JCO.2009.25.7899
    electronic publication date
    display
    2010 Mar 1
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20194851
    immutable id
    pubmed:20194851@a3de9c3b504cc686e78d256bd5b010c250a648c9fabdaf646c84abb7bc8bac4a
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    10
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1772-9
    volume
    28
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20194851
      provenance
      batch id
      708c7929ee1eff455330
      provider
      NCBI PubMed ESummary
      record sha256
      566ca0dc78e9aaa86a3d9159cef0458ba6b4448c8f7fc879e09d55677a043625
      response sha256
      d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
      retrieved at
      2026-09-09T23:46:31.496840+00:00
      publication date
      display
      2010 Apr 1
      precision
      day
      year
      2010
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20194851/
      title
      Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

      Preserved source evidence · Not medical advice